These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38083740)

  • 21. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
    Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study.
    Wang T; Wang X; Yao Y; Zhao C; Yang C; Han Y; Cai Y
    BMJ Open; 2022 Apr; 12(4):e054347. PubMed ID: 35387811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
    Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
    Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment.
    Sanabria-Diaz G; Martínez-Montes E; Melie-Garcia L;
    PLoS One; 2013; 8(7):e68860. PubMed ID: 23894356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered pattern analysis and identification of subjective cognitive decline based on morphological brain network.
    Xu X; Chen P; Xiang Y; Xie Z; Yu Q; Zhou X; Wang P
    Front Aging Neurosci; 2022; 14():965923. PubMed ID: 36034138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
    Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of APOEε4 on Functional Brain Network in Patients with Subjective Cognitive Decline: A Resting State Functional MRI Study.
    Deng S; Sun L; Chen W; Liu X; Chen S
    Int J Gen Med; 2021; 14():9761-9771. PubMed ID: 34934350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.
    Adriaanse SM; Wink AM; Tijms BM; Ossenkoppele R; Verfaillie SC; Lammertsma AA; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
    Brain Connect; 2016 Feb; 6(1):1-8. PubMed ID: 26414628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E ε4 modulates functional brain connectome in Alzheimer's disease.
    Wang J; Wang X; He Y; Yu X; Wang H; He Y
    Hum Brain Mapp; 2015 May; 36(5):1828-46. PubMed ID: 25619771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.
    Marchitelli R; Aiello M; Cachia A; Quarantelli M; Cavaliere C; Postiglione A; Tedeschi G; Montella P; Milan G; Salvatore M; Salvatore E; Baron JC; Pappatà S
    Neuroimage; 2018 Aug; 176():246-258. PubMed ID: 29709628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
    Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
    Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural brain network correlations with amyloid burden in elderly individuals at risk of Alzheimer's disease.
    Ota M; Numata Y; Kitabatake A; Tsukada E; Kaneta T; Asada T; Meno K; Uchida K; Suzuki H; Korenaga T; Arai T
    Psychiatry Res Neuroimaging; 2022 Jan; 319():111415. PubMed ID: 34839208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations Between Positron Emission Tomography Amyloid Pathology and Diffusion Tensor Imaging Brain Connectivity in Pre-Clinical Alzheimer's Disease.
    Hwang SJ; Adluru N; Kim WH; Johnson SC; Bendlin BB; Singh V
    Brain Connect; 2019 Mar; 9(2):162-173. PubMed ID: 30255713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.